InvestorsHub Logo
Replies to #76299 on Biotech Values

masterlongevity

04/21/09 2:00 AM

#76313 RE: apljack #76299

actually i was referring to the status of the 1st gamma secretase inhibitor phase 3 that began enrolling in March 2008.


I'm not sure what they are about to start, but they began enrolling in their 1st ph 3 in Mar 08 and in the 2nd phase 3 in July 08.